首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
RivoceranibVarious toxicities
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2024年
/ 2000卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-024-55009-y
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:320 / 320
相关论文
共 50 条
[31]
Gimeracil/oteracil/tegafur/imatinib/rivoceranibVarious toxicities: case report
Reactions Weekly,
2021,
1858
(1)
: 171
-
171
[32]
Camrelizumab/Potassium-chloride/RivoceranibVarious toxicities: case report
Reactions Weekly,
2025,
2041
(1)
: 93
-
93
[33]
Camrelizumab/irinotecan/rivoceranibVarious toxicities and lack of efficacy: 6 case reports
Reactions Weekly,
2023,
1986
(1)
: 119
-
119
[34]
RivoceranibVarious toxicities following off-label use: case report
Reactions Weekly,
2020,
1786
(1)
: 149
-
149
[35]
Docetaxel/gimeracil/oteracil/tegafur/rivoceranibVarious toxicities: 7 case reports
Reactions Weekly,
2019,
1758
(1)
: 155
-
155
[36]
Programmed-cell-death-1-receptor-antagonists/rivoceranibVarious toxicities: 3 case reports
Reactions Weekly,
2020,
1833
(1)
: 331
-
331
[37]
RivoceranibVarious toxicites: case report
Reactions Weekly,
2018,
1709
(1)
: 228
-
228
[38]
RivoceranibVarious toxcities: case report
Reactions Weekly,
2018,
1719
(1)
: 207
-
207
[39]
RivoceranibVarious toxicites: 4 case reports
Reactions Weekly,
2019,
1774
(1)
: 283
-
283
[40]
Pyrotinib/rivoceranibVarious toxicites: case report
Reactions Weekly,
2020,
1790
(1)
: 199
-
199
←
1
2
3
4
5
→